Literature DB >> 2012178

Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis.

C F Moyer1, D Sajuthi, H Tulli, J K Williams.   

Abstract

Interleukin-1 (IL-1) has been implicated as a regulatory protein in the development and clinical sequelae of atherosclerosis. To determine which cells in the atherosclerotic plaque synthesize IL-1 in situ, the authors evaluated histologic sections of iliac arteries from cynomolgus monkeys using probes for IL-1 alpha and beta. A polyclonal antibody to IL-1 alpha and beta was used to determine if proteins were concomitantly produced. The predominant cells expressing IL-1 alpha and beta mRNA were foam cells in the intima. Adherent leukocytes and vascular smooth muscle cells (VSMCs) expressed mRNA for IL-1 alpha. Microvascular endothelium expressed mRNA for both IL-1 alpha and beta. IL-1 proteins were located frequently in cells expressing IL-1 mRNA. These results indicate that endothelium and VSMCs, in conjunction with macrophages, serve as localized sources of IL-1 protein synthesis. These findings suggest that vascular cells may contribute directly to the pathogenesis of atherosclerotic vascular disease by actively secreting potent biologic mediators that modify vascular and immune cell function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012178      PMCID: PMC1886091     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization.

Authors:  J N Wilcox; K M Smith; L T Williams; S M Schwartz; D Gordon
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

Review 2.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

Authors:  J S Pober
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

3.  Intracellular accumulation of cholesteryl esters suppresses production of lipopolysaccharide-induced interleukin 1 by rat peritoneal macrophages.

Authors:  Y Haga; K Takata; N Araki; K Sakamoto; M Akagi; Y Morino; S Horiuchi
Journal:  Biochem Biophys Res Commun       Date:  1989-04-28       Impact factor: 3.575

4.  Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte derived growth factor.

Authors:  P D Bonin; G J Fici; J P Singh
Journal:  Exp Cell Res       Date:  1989-04       Impact factor: 3.905

5.  IL-1 and IFN-gamma increase vascular permeability.

Authors:  S Martin; K Maruta; V Burkart; S Gillis; H Kolb
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

Review 6.  Interleukin 1: the first interleukin.

Authors:  F S di Giovine; G W Duff
Journal:  Immunol Today       Date:  1990-01

Review 7.  Immune mechanisms in atherosclerosis.

Authors:  G K Hansson; L Jonasson; P S Seifert; S Stemme
Journal:  Arteriosclerosis       Date:  1989 Sep-Oct

8.  Detection of IL-1 alpha and IL-1 beta in the supernatants of paraformaldehyde-treated human monocytes. Evidence against a membrane form of IL-1.

Authors:  J Suttles; L M Carruth; S B Mizel
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

9.  The modulatory effect of lipoproteins on the release of interleukin 1 by human peritoneal macrophages stimulated with beta-1,3-D-polyglucose derivatives.

Authors:  L T Rasmussen; R Seljelid
Journal:  Scand J Immunol       Date:  1989-04       Impact factor: 3.487

10.  Quantitation of mRNA by the polymerase chain reaction.

Authors:  A M Wang; M V Doyle; D F Mark
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more
  52 in total

Review 1.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

2.  IL-1 receptor accessory protein-Ig/IL-1 receptor type II-Ig heterodimer inhibits IL-1 response more strongly than other IL-1 blocking biopharmaceutical agents.

Authors:  Haruo Hanawa; Yoshimi Ota; Limin Ding; He Chang; Kaori Yoshida; Keita Otaki; Kazuhisa Hao; Sou Kasahara; Makoto Kodama; Mikio Nakazawa; Yoshifusa Aizawa
Journal:  J Clin Immunol       Date:  2010-12-22       Impact factor: 8.317

Review 3.  Vascular endothelial senescence: from mechanisms to pathophysiology.

Authors:  Jorge D Erusalimsky
Journal:  J Appl Physiol (1985)       Date:  2008-11-26

Review 4.  How metabolism generates signals during innate immunity and inflammation.

Authors:  Anne F McGettrick; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2013-06-24       Impact factor: 5.157

Review 5.  Helper T cells and atherosclerosis: the cytokine web.

Authors:  S G Baidya; Q-T Zeng
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

Review 6.  The role of the inflammasome in cardiovascular diseases.

Authors:  Xuan Li; Nicolas Deroide; Ziad Mallat
Journal:  J Mol Med (Berl)       Date:  2014-03-19       Impact factor: 4.599

7.  Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis.

Authors:  H Kishikawa; T Shimokama; T Watanabe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  Transport of interleukin-1 across cerebromicrovascular endothelial cells.

Authors:  R A Skinner; R M Gibson; N J Rothwell; E Pinteaux; J I Penny
Journal:  Br J Pharmacol       Date:  2009-03-04       Impact factor: 8.739

9.  Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets.

Authors:  N Clausell; M Rabinovitch
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

10.  The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.

Authors:  Jeff C Huffman; Christopher M Celano; James L Januzzi
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.